161 related articles for article (PubMed ID: 7701953)
21. Local anesthetic and antiarrhythmic effect of some imidazolidin-2-one derivatives.
Librowski T; Filipek B; Czarnecki R
Acta Pol Pharm; 2000; 57(5):391-6. PubMed ID: 11126032
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antiarrhythmic properties of basic amide derivatives of imidazolidine-2,4-dione and pyrrolidine-2,5-dione II.
Kieć-Kononowicz K; Byrtus H; Zejc A; Filipek B; Chevallet P
Farmaco; 1995 May; 50(5):355-60. PubMed ID: 7626171
[TBL] [Abstract][Full Text] [Related]
23. [Synthesis and anti-arrhythmia activity of 5-benzylidene-imidazoline-4-one derivatives].
Bousquet E; Pappalardo G
Boll Chim Farm; 1979 Jan; 118(1):23-7. PubMed ID: 454527
[No Abstract] [Full Text] [Related]
24. [Search for new beta-adrenoblockaders among derivatives of (3-amino-2-hydroxypropoxy) phenoxymethyl isoxazole].
Iuzhakov SD; Sokolov SD; Vinogradova SM
Farmakol Toksikol; 1988; 51(4):47-52. PubMed ID: 2903834
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone.
Szkaradek N; Rapacz A; Pytka K; Filipek B; Siwek A; Cegła M; Marona H
Bioorg Med Chem; 2013 Jan; 21(2):514-22. PubMed ID: 23245804
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological properties of some aminoalkanolic derivatives of xanthone.
Marona H; Pekala E; Filipek B; Maciag D; Szneler E
Pharmazie; 2001 Jul; 56(7):567-72. PubMed ID: 11487977
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacological study of 3-alkyl-5-(cycloalkoxymethyl)oxazolidines].
Staneva D; Chakŭrova L; Pulev A
Eksp Med Morfol; 1982; 21(3):148-54. PubMed ID: 7173107
[No Abstract] [Full Text] [Related]
28. (RS), (R)(-) and (S)(+) derivatives of 2-N-arylalkylamino-1-butanol having antiarrhythmic properties.
Eckstein M; Zajaczkowska J; Samochowiec L
Pol J Pharmacol Pharm; 1988; 40(4):401-11. PubMed ID: 3222179
[TBL] [Abstract][Full Text] [Related]
29. [The anti-arrhythmic activity of quinuclidine derivatives].
Svistov AS; Skorobogatov VI
Eksp Klin Farmakol; 1994; 57(5):20-1. PubMed ID: 7696896
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach.
Bhandari SV; Bothara KG; Patil AA; Chitre TS; Sarkate AP; Gore ST; Dangre SC; Khachane CV
Bioorg Med Chem; 2009 Jan; 17(1):390-400. PubMed ID: 19036593
[TBL] [Abstract][Full Text] [Related]
31. [The anti-arrhythmia activity of new dicyclohexylamide derivatives of N-substituted alpha-aminocarboxylic acids].
Berdiaev SU; Paliani-Katsitadze NSh; Turilova AI; Kaverina NV; Likhosherstov AM; Lebedeva AS; Ogurtsov VA
Eksp Klin Farmakol; 1999; 62(4):26-9. PubMed ID: 10513331
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and local anesthetic and circulatory actions of aminoesters and hydroxyamine monoterpene derivatives.
Siemieniuk A; Szałkowska-Pagowska H; Lochyński S; Piatkowski K; Filipek B; Krupińska J; Czarnecki R; Librowski T; Zebala K
Pol J Pharmacol Pharm; 1992; 44(4):407-20. PubMed ID: 1287604
[TBL] [Abstract][Full Text] [Related]
33. [2-(2'-hydroxy 2'-substituted) ethyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazines--a novel group of substances with anti-arrhythmia activity].
Filippova OV; Kryzhanovskiĭ SA; Peresada VP; Likhosherstov AM; Vititnova MB; Kaverina NV; Reznikov KM
Eksp Klin Farmakol; 2003; 66(3):21-5. PubMed ID: 12924227
[TBL] [Abstract][Full Text] [Related]
34. [Antiarrhythmic properties of 2-(2'-hydroxy-2')-substituted ethyl-1,2,3,4-octahydropyrrolo[1,2-a]pyrazines].
Filippova OV; Kryzhanovskiĭ SA; Peresada VP; Likhosherstov AM; Revenko SV; Kaverina NV; Reznikov KM
Eksp Klin Farmakol; 2004; 67(4):26-9. PubMed ID: 15500041
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
[TBL] [Abstract][Full Text] [Related]
36. Esters of 7-(diphenylmethylene)bicyclo[2.2.1]heptan-2-endo-ol with antiarrhythmic and other activities.
Longobardi M; Bargagna A; Mariani E; Schenone P; Russo S; De Paola C; Stella L; Donnoli D; Falzarano C; Marmo E
Farmaco; 1991 May; 46(5):647-56. PubMed ID: 1953925
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study of the activity of anti-arrhythmia agents in calcium chloride-induced arrhythmia in mice].
Gorbunova VV; Gorbunov NP
Farmakol Toksikol; 1983; 46(3):48-50. PubMed ID: 6861988
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and pharmacological evaluation of respiratory stimulant amides of imidazo(1,2-a)pyridine-2,3-dicarboxylic acids.
Casagrande C; Ferrini R; Miragoli G; Ferrari G
Farmaco Sci; 1972 Sep; 27(9):715-30. PubMed ID: 4666083
[No Abstract] [Full Text] [Related]
39. Synthesis, physicochemical and preliminary pharmacological properties of N-[beta-hydroxy-gamma-(N-phenylpiperazinepropyl)]-2-pyrrolidinone.
Malawska B; Gorczyca M; Filipek B
Pol J Pharmacol Pharm; 1992; 44(6):561-74. PubMed ID: 1305957
[TBL] [Abstract][Full Text] [Related]
40. [The anti-arrhythmic activity of the arylamides of alpha-hexamethyleneiminocarboxylic acids].
Berdiaev SIu; Turilova AI; Lebedeva AS; Likhosherstov AM; Ninidze IG; Kaverina NV; Skoldinov AP
Farmakol Toksikol; 1991; 54(3):32-4. PubMed ID: 1915816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
